() () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () () ()

Tag Archives: Conversion of Debentures

Organigram Announces Conversion of $98 Million Debentures Into Common Shares

Organigram Holdings Inc. (TSX VENTURE: OGI) (OTCQX: OGRMF), announced today that the Company has elected to exercise its right under the indenture (the "Indenture") governing the Company's 6.0% convertible unsecured debentures due January 31, 2020 (the "Debentures") to convert (the "Conversion") all of the principal amount outstanding of the remaining Debentures on April 1, 2019 (the "Conversion Date") into common shares of the Company (the "Common Shares").
Read more

Origin House Announces Conversion of Debentures to Further Strengthen its Balance Sheet

Feb. 26, 2019 /CNW/ - CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) ("Origin House" or the "Company"), a leading North American cannabis products and brands company, today announced that the Company has elected to exercise its rights under the indenture dated July 12, 2018 (the "Indenture"), governing the Company's 8% unsecured convertible debentures due July 12, 2021 (the "Debentures") to convert the principal amount of the outstanding Debentures to common shares of the Company ("Common Shares").
Read more

Relevium Technologies Announces Conversion of Debentures and Strenghtens Balance Sheet

Relevium Technologies Inc. (TSX.V:“RLV”, OTCQB:“RLLVF” and Frankfurt: “6BX”) (the “Company” or “Relevium”), is pleased to announce it has received notices to convert (the "Conversion") all of the principal amount outstanding of the remaining debentures due June 2019 (the "Debentures) into common shares of the Company (the "Common Shares") at a price of 0.15$ per share.
Read more

Aurora Cannabis Announces Conversion of Debentures

Oct. 17, 2018 /CNW/ - Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company has elected to exercise its right under the indenture (the "Indenture") governing the Company's 6.0% unsecured convertible debentures due November 28, 2022 (the "Debentures") to convert (the "Conversion") all of the principal amount outstanding of the remaining Debentures up to November 16, 2018 into common shares of the Company (the "Common Shares"). Pursuant to the terms of the Indenture, the Company may force the conversion of the Debentures at the conversion price of $6.50 per Common Share when the VWAP of the Common Shares on the TSX Exchange (the "Exchange") for 10 consecutive trading days equals or exceeds $9.00.
Read more